# Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis

> **NCT05326126** · NA · COMPLETED · sponsor: **Matteo Montorfano** · enrollment: 75 (actual)

## Conditions studied

- Severe Symptomatic Aortic Stenosis

## Interventions

- **DEVICE:** coronary physiology

## Key facts

- **NCT ID:** NCT05326126
- **Lead sponsor:** Matteo Montorfano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-08
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05326126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05326126, "Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05326126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*